Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SL-28 in Advanced Solid Tumours
NCT07341737Phase 2Recruiting
- Sponsor
- Second Life Therapeutics, Inc.
- Start
- Aug 2026
- Primary completion
- Jan 2027
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of SL-28 in solid tumor, sponsored by Second Life Therapeutics, Inc.. Started Aug 2026; status: recruiting.
02
Drugs
SL-28
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT07341737.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07341737.